BioCorRx
Manufacturing · California, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
2390 E Orangewood Ave Ste 575, Anaheim, ...Phone Number
(714) 462-4880Website
www.biocorrx.comRevenue
<$5 MillionIndustry
About BioCorRx
BioCorRx Pharmaceuticals, Inc. is a biotechnology company focused on developing innovative treatments for substance use disorders, including opioid, alcohol, and methamphetamine use disorders. Their lead product, BICX104, is an implantable, long-acting naltrexone pellet designed to provide a sustained treatment option that may enhance patient compliance and reduce relapse rates. The company is currently advancing BICX104 through clinical trials and has received FDA clearance for its investigational new drug application. BioCorRx Pharmaceuticals aims to serve patients struggling with substance use disorders by offering effective and biodegradable treatment solutions.Explore more
BioCorRx Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to BioCorRx
Compare insights from companies similar to BioCorRx, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
BioCorRx Tech Stack
A closer look at the technologies used by BioCorRx
Top Manufacturing Companies
Frequently Asked Questions Regarding BioCorRx
Sign Up For FreeTo access detailed company insights
BioCorRx Pharmaceuticals, Inc. is a biotechnology company focused on developing innovative treatments for substance use disorders, including opioid, alcohol, and methamphetamine use disorders. Their lead product, BICX104, is an implantable, long-acting naltrexone pellet designed to provide a sustained treatment option that may enhance patient compl... Read More
